Pharma Major Lupin (Lupin) and MSD,
one of the world’s leading players in 23-valent Pneumococcal Polysaccharide
Vaccines category has formed an India-specific strategic partnership. Within
the scope of the partnership, Lupin will have a non-exclusive license to
market, promote and distribute MSD’s 23-valent Pneumococcal Polysaccharide
Vaccine under a different brand name in India. Thursday, July 18, 2013
Epic Update : Lupin Pharma
Pharma Major Lupin (Lupin) and MSD,
one of the world’s leading players in 23-valent Pneumococcal Polysaccharide
Vaccines category has formed an India-specific strategic partnership. Within
the scope of the partnership, Lupin will have a non-exclusive license to
market, promote and distribute MSD’s 23-valent Pneumococcal Polysaccharide
Vaccine under a different brand name in India. 
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment